Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.570
+0.068 (13.51%)
Nov 7, 2024, 4:00 PM EST - Market closed
Unicycive Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 7, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 54 | 30 | 8 | 31 | - | - | |
Market Cap Growth | -3.36% | 270.11% | -73.58% | - | - | - | |
Enterprise Value | 59 | 17 | 1 | 13 | - | - | |
Last Close Price | 0.57 | 0.87 | 0.54 | 2.06 | - | - | |
PE Ratio | - | -0.68 | -0.45 | -2.40 | - | - | |
PS Ratio | - | 44.68 | 8.57 | - | - | - | |
PB Ratio | 0.60 | -7.92 | -17.48 | 1.87 | - | - | |
P/FCF Ratio | -0.87 | -1.65 | -0.52 | -5.32 | - | - | |
P/OCF Ratio | -0.87 | -1.65 | -0.52 | -5.35 | - | - | |
EV/Sales Ratio | - | 24.77 | 1.40 | - | - | - | |
EV/EBITDA Ratio | -0.58 | -0.81 | -0.07 | -1.44 | - | - | |
EV/EBIT Ratio | -0.58 | -0.80 | -0.07 | -1.44 | - | - | |
EV/FCF Ratio | -0.78 | -0.91 | -0.09 | -2.23 | - | - | |
Debt / Equity Ratio | 0.02 | -0.21 | -0.33 | 0.02 | -0.94 | -0.52 | |
Debt / FCF Ratio | -0.03 | -0.04 | -0.01 | -0.05 | -1.72 | -0.39 | |
Asset Turnover | - | 0.08 | 0.09 | - | - | - | |
Quick Ratio | 3.19 | 0.55 | 0.14 | 7.88 | - | 0.02 | |
Current Ratio | 3.37 | 0.76 | 0.81 | 8.75 | 0.07 | 0.02 | |
Return on Equity (ROE) | -121.76% | - | -225.47% | -145.04% | - | - | |
Return on Assets (ROA) | -53.37% | -152.67% | -104.65% | -59.22% | -1132.29% | -5111.98% | |
Return on Capital (ROIC) | -90.76% | - | -136.93% | -67.46% | - | - | |
Earnings Yield | -45.39% | -101.29% | -221.63% | -32.48% | - | - | |
FCF Yield | -40.29% | -60.67% | -192.11% | -18.79% | - | - | |
Buyback Yield / Dilution | -131.65% | -62.98% | -28.96% | -37.37% | -4.68% | -20.35% | |
Total Shareholder Return | -131.65% | -62.98% | -28.96% | -37.37% | -4.68% | -20.35% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.